Sanuwave Health (NASDAQ:SNWV) Releases Earnings Results

Sanuwave Health (NASDAQ:SNWV) posted its quarterly earnings results on Tuesday. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.17), FiscalAI reports. The firm had revenue of $8.58 million during the quarter, compared to the consensus estimate of $13.75 million. Sanuwave Health had a return on equity of 1,728.10% and a net margin of 32.38%.

Sanuwave Health Price Performance

Shares of SNWV stock traded up $0.03 during mid-day trading on Tuesday, hitting $1.88. The company had a trading volume of 92,741 shares, compared to its average volume of 113,433. The company has a debt-to-equity ratio of 4.87, a current ratio of 1.28 and a quick ratio of 0.89. The stock’s 50 day moving average price is $4.73 and its 200-day moving average price is $12.91. Sanuwave Health has a 52-week low of $1.75 and a 52-week high of $36.20. The company has a market capitalization of $16.17 million, a P/E ratio of 7.83 and a beta of 1.47.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Sanuwave Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, November 4th. One equities research analyst has rated the stock with a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Sanuwave Health currently has an average rating of “Reduce” and a consensus target price of $47.00.

About Sanuwave Health

SANUWAVE Health, Inc. is a medical technology company focused on regenerative medicine and advanced wound-care solutions. The company develops and commercializes noninvasive devices that use extracorporeal shock wave technology to stimulate biological responses in damaged or difficult-to-heal tissue. Its principal product is the dermaPACE system, which is designed to deliver acoustic shock waves to wound areas, including chronic diabetic foot ulcers. SANUWAVE has also pursued additional applications for its platform in areas such as orthopedic and soft-tissue healing, although the availability and regulatory status of specific products may vary by geography.